Mindbodygreen iconMindbodygreenSep 18, 2026 ~4 min source read

Could Ashwagandha Help After Menopause? A 12-Week Trial’s Practical Takeaways

A small randomized trial tested 600 mg daily of ashwagandha root extract in postmenopausal women for 12 weeks and found improvements in sleep, menopause symptoms, quality of life, and a small change in body-fat percentage, with no short-term effect on bone density.

Could This Popular Stress Supplement Be A Menopause Multitasker?

Share this story

Send the public story page.

Useful takeaways from this story.

In a 12-week randomized trial of 66 women (63 completers), 600 mg/day ashwagandha improved sleep quality and several menopause symptoms more than placebo.

The trial was small and conducted at a single center in Amritsar, India, so results are preliminary and may not generalize broadly.

Many people take ashwagandha for stress and sleep. This randomized, double-blind trial tested whether the herb could also help common postmenopausal changes: sleep disruption, hot flashes and other menopause symptoms, body composition, and early changes in bone density.

Researchers enrolled 66 women ages 45 to 65 who had completed menopause. Participants were randomly assigned to take 600 milligrams of ashwagandha root extract daily or a placebo for 12 weeks. Neither participants nor researchers knew who received which treatment. Three women dropped out, leaving 63 who finished the study. Outcomes tracked included sleep quality, menopause symptoms, quality of life, body composition (including body-fat percentage), and bone density.

  • Menopause symptoms and quality of life: Symptoms improved significantly more in the ashwagandha group than in the placebo group, and quality-of-life measures rose across several areas for those taking the herb.
  • Body composition: Body-fat percentage decreased in the ashwagandha group while it edged up in the placebo group. Changes were described as slight.
  • Bone density: No between-group difference after 12 weeks. The authors note that bone changes usually require longer follow-up to detect.
  • Safety: The supplement was generally well tolerated and no serious side effects were reported during the trial.

The trial suggests potential benefits of ashwagandha beyond stress support, particularly for sleep and some menopause symptoms over a 12-week period. But there are important limits:

  • Sample and setting: The study was small and ran at a single center in Amritsar, India. That reduces confidence that results would be the same in a larger or more diverse population.
  • Duration: Twelve weeks is enough to detect changes in sleep and symptoms but is too short to evaluate long-term effects on bone health or sustained body-composition shifts.
  • Product specifics: The trial used a specific 600 mg root-extract formulation. Other ashwagandha products can differ in extract type and potency, so outcomes may not apply to all supplements.
  • If you're considering ashwagandha, consult your healthcare provider first, especially if you take medications or have health conditions.
  • Treat troublesome symptoms with medical advice. Menopause hormone therapy and other evidence-based options remain available and may be more appropriate depending on your symptom profile.

More context around this story.

Loading more related stories...

Keep reading in the app

Open the app view to save this story, compare related coverage, and continue from the same source.

Open in app